164 related articles for article (PubMed ID: 31535070)
1. Treatment of Head and Neck Venous Malformations with Sodium Tetradecyl Sulfate.
Karimi E; Jafari M; Aghazadeh K; Sohrabpour S; Tavakolnejad F
OTO Open; 2018; 2(3):2473974X18797067. PubMed ID: 31535070
[TBL] [Abstract][Full Text] [Related]
2. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
[TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy of craniofacial venous malformations: complications and results.
Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol).
Siniluoto TM; Svendsen PA; Wikholm GM; Fogdestam I; Edström S
Scand J Plast Reconstr Surg Hand Surg; 1997 Jun; 31(2):145-50. PubMed ID: 9232699
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.
Park HS; Do YS; Park KB; Kim KH; Woo SY; Jung SH; Kim DI; Kim YW; Hyun D; Cho SK; Choo IW
Eur Radiol; 2016 May; 26(5):1301-10. PubMed ID: 26307182
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations.
Farnoosh S; Don D; Koempel J; Panossian A; Anselmo D; Stanley P
Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):883-887. PubMed ID: 25887132
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate.
O'Donovan JC; Donaldson JS; Morello FP; Pensler JM; Vogelzang RL; Bauer B
AJR Am J Roentgenol; 1997 Sep; 169(3):723-9. PubMed ID: 9275886
[TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
Odeyinde SO; Kangesu L; Badran M
J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
[TBL] [Abstract][Full Text] [Related]
11. Sclerotherapy using 1% sodium tetradecyl sulfate to treat a vascular malformation: a report of two cases.
Min HG; Kim SG; Oh JS; You JS
J Korean Assoc Oral Maxillofac Surg; 2015 Dec; 41(6):322-6. PubMed ID: 26734559
[TBL] [Abstract][Full Text] [Related]
12. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
Khandpur S; Sharma VK
Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
[TBL] [Abstract][Full Text] [Related]
13. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
14. Balloon occlusion as an adjunctive technique during sclerotherapy of Puig's classified advanced venous malformations.
Sundararajan SH; Ranganathan S; Shellikeri S; Srinivasan A; Low DW; Pukenas B; Hurst R; Cahill AM
Phlebology; 2021 Oct; 36(9):731-740. PubMed ID: 33983079
[TBL] [Abstract][Full Text] [Related]
15. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
[TBL] [Abstract][Full Text] [Related]
16. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children.
Stuart S; Barnacle AM; Smith G; Pitt M; Roebuck DJ
Radiology; 2015 Mar; 274(3):897-905. PubMed ID: 25271855
[TBL] [Abstract][Full Text] [Related]
17. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center.
Ali S; Weiss CR; Sinha A; Eng J; Mitchell SE
Phlebology; 2016 Oct; 31(9):603-9. PubMed ID: 27009607
[TBL] [Abstract][Full Text] [Related]
18. Chronic facial pain following injection of sodium tetradecyl sulphate into an intraparotid haemolymphangioma.
Crampsey DP; Cochrane L; Roebuck D; Hartley BE
J Laryngol Otol; 2008 Sep; 122(9):1002-4. PubMed ID: 17625033
[TBL] [Abstract][Full Text] [Related]
19. Low flow vascular malformation of the buccal mucosa treated conservatively by sclerotherapy (3% sodium tetradecyl sulfate).
Candamourty R; Venkatachalam S; Babu MR; Reddy VK
J Nat Sci Biol Med; 2012 Jul; 3(2):195-8. PubMed ID: 23225986
[TBL] [Abstract][Full Text] [Related]
20. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
